The presence of MF-1 fibrosis, CALR mutation, and t(15;17)-driven NF1::SCAMP5 fusion may represent an atypical molecular–pathological profile warranting reclassification as “provisional MPN with unique genetic features” until further cases are reported. This evidence concerns the gene CALR and myeloproliferative disorder.